Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2021

View Archived Issues

CCR6 antagonist PF-07054894 for autoimmune disorders

International researchers discover first nonhormonal treatment target for endometriosis

Increased atrial proarrhythmic activity seen in murine model of OSA

Janssen Biotech divulges DHODH inhibitors

Mindset Pharma patents 5-HT2A receptor agonists

TroBio Therapeutics presents new compounds for cancer

U.K. researchers synthesize new antifungals

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

New heart failure animal model also captures arrhythmia susceptibility

Low-dose targeted radionuclide therapy using [90Y]NM-600 promotes response to ICIs

New class of Mcl-1 inhibitors developed at Janssen for treating myeloma

Investigators identify new gene mutations behind hereditary optic neuropathy

Preclinical data highlight CAN-04 mode of action in potentiating efficacy of docetaxel

Genexine divulges new anti-PD-L1 fusion proteins

Satellos determines high-resolution crystal structure of target for Duchenne muscular dystrophy

Sonnet selects SON-1410 as development candidate for melanoma and renal cancers

Type of RPE65 variant is associated with age at onset of inherited retinal dystrophies

New genes identified to cause nonsyndromic cleft palate

Polymorphisms in the IRAK2 gene are associated with RA susceptibility

hsa-miR-34b-5p as novel diagnostic marker in male infertility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...